nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.05.2022 | Rapid Communication

Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion

verfasst von: B. Pla Peris, A. Á. Merchante Alfaro, F. J. Maravall Royo, P. Abellán Galiana, S. Pérez Naranjo, M. González Boillos

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Aim

To describe a case series of thyrotoxicosis likely triggered by SARS-CoV-2 vaccination and to warn physicians about this potential correlation. To report clinical, laboratory and imaging findings and provide further information that goes in line with the underlying mechanisms.

Methods

Single-center case series based on all the information collected in the hospital medical records, as well as the temporal sequence between the onset of symptoms and COVID-19 vaccination.

Results

We report 8 cases with thyrotoxicosis after SARS-CoV-2 vaccination. 4 cases of Graves’ disease (GD), 2 cases of subacute painful thyroiditis (SAT), 1 case of concurrent GD and SAT and 1 case of atypical subacute thyroiditis. Five patients received BNT162b2 mRNA vaccine, 3 patients 1273 mRNA vaccine. The onset of symptoms following vaccination ranged from 10 to 14 days in six of eight patients and from 7 to 8 weeks in two patients.

Conclusions

Several hypotheses have been proposed to explain the potential correlation between SARS-CoV-2 vaccination and thyrotoxicosis, including immune system hyper-stimulation, molecular mimicry and Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants (ASIA). We should pay greater attention to thyroid disorders in patients receiving vaccine against SARS-CoV-2.

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update. Last day access 04/11/21

Brancatella A, Ricci D, Cappellani D et al (2020) Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa537CrossRefPubMed

Bossoni S, Chiesa L, Giustina A (2020) Severe hypocalcemia in a thyroidectomized woman with COVID-19 infection. Endocrine 68(2):253–254. https://doi.org/10.1007/s12020-020-02326-0CrossRefPubMedPubMedCentral

Boddu SK, Aurangabadkar G, Kuchay MS (2020) New onset diabetes, type 1 diabetes and COVID-19. Diabetes Metab Syndr 14(6):2211–2217. https://doi.org/10.1016/j.dsx.2020.11.012CrossRefPubMedPubMedCentral

Lee KA, Kim YJ, Jin HY (2021) Thyrotoxicosis after COVID-19 vaccination: seven case reports and a literature review. Endocrine. https://doi.org/10.1007/s12020-021-02898-5CrossRefPubMedPubMedCentral

Hannah Ritchie, Edouard Mathieu, Lucas Rodés-Guirao, Cameron Appel, Charlie Giattino, Esteban Ortiz-Ospina, Joe Hasell, Bobbie Macdonald, Diana Beltekian and Max Roser (2020)—“Coronavirus Pandemic (COVID-19)”. Published online at OurWorldInData.org. Retrieved from: https://ourworldindata.org/coronavirus [Online Resource]. Last day access 04/11/21

Brancatella A, Ricci D, Viola N, Sgrò D, Santini F, Latrofa F (2020) Subacute thyroiditis after Sars-COV-2 infection. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa276CrossRefPubMed

Garg MK, Gopalakrishnan M, Yadav P, Misra S (2020) Endocrine involvement in COVID-19: mechanisms, clinical features, and implications for care. Indian J Endocrinol Metab 24(5):381–386. https://doi.org/10.4103/ijem.IJEM_440_20CrossRefPubMedPubMedCentral

Jiménez-Blanco S, Pla-Peris B, Marazuela M (2021) COVID-19: a cause of recurrent Graves’ hyperthyroidism? J Endocrinol Invest 44(2):387–388. https://doi.org/10.1007/s40618-020-01440-0CrossRefPubMed

10.

Lanzolla G, Marcocci C, Marinò M (2021) Graves’ disease and Graves’ orbitopathy following COVID-19. J Endocrinol Invest 44(9):2011–2012. https://doi.org/10.1007/s40618-021-01576-7CrossRefPubMed

11.

Marazuela M, Giustina A, Puig-Domingo M (2020) Endocrine and metabolic aspects of the COVID-19 pandemic [published correction appears in Rev Endocr Metab Disord. 2021 Mar; 22(1):145]. Rev Endocr Metab Disord 21(4):495–507. https://doi.org/10.1007/s11154-020-09569-2CrossRefPubMedPubMedCentral

12.

Muller I, Cannavaro D, Dazzi D et al (2020) SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol 8(9):739–741. https://doi.org/10.1016/S2213-8587(20)30266-7CrossRefPubMedPubMedCentral

13.

Blanco-Melo D, Nilsson-Payant BE, Liu WC et al (2020) Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181(5):1036-1045.e9. https://doi.org/10.1016/j.cell.2020.04.026CrossRefPubMedPubMedCentral

14.

Montebello A (2021) Recurrent Graves’ disease post SARS-CoV-2 infection. BMJ Case Rep 14(8):e244714. https://doi.org/10.1136/bcr-2021-244714CrossRefPubMedPubMedCentral

15.

Siolos A, Gartzonika K, Tigas S (2021) Thyroiditis following vaccination against COVID-19: report of two cases and review of the literature. Metabol Open 12:100136. https://doi.org/10.1016/j.metop.2021.100136CrossRefPubMedPubMedCentral

16.

İremli BG, Şendur SN, Ünlütürk U (2021) Three cases of subacute thyroiditis following SARS-CoV-2 vaccine: post-vaccination ASIA syndrome. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgab373CrossRefPubMed

17.

Bornemann C, Woyk K, Bouter C (2021) Case report: two cases of subacute thyroiditis following SARS-CoV-2 vaccination. Front Med (Lausanne). 8:737142. https://doi.org/10.3389/fmed.2021.737142CrossRefPubMedPubMedCentral

18.

Oyibo SO (2021) Subacute thyroiditis after receiving the adenovirus-vectored vaccine for coronavirus disease (COVID-19). Cureus 13(6):e16045. https://doi.org/10.7759/cureus.16045CrossRefPubMedPubMedCentral

19.

Watad A, David P, Brown S, Shoenfeld Y (2017) Autoimmune/inflammatory syndrome induced by adjuvants and thyroid autoimmunity. Front Endocrinol (Lausanne). 7:150. https://doi.org/10.3389/fendo.2016.00150CrossRefPubMedPubMedCentral

20.

Liang Z, Zhu H, Wang X et al (2020) Adjuvants for coronavirus vaccines. Front Immunol 11:589833. https://doi.org/10.3389/fimmu.2020.589833CrossRefPubMedPubMedCentral

21.

Lui DTW, Lee KK, Lee CH, Lee ACH, Hung IFN, Tan KCB (2021) Development of Graves’ disease after SARS-CoV-2 mRNA vaccination: a case report and literature review. Front Public Health 9:778964. https://doi.org/10.3389/fpubh.2021.778964CrossRefPubMedPubMedCentral

22.

Bragazzi NL, Hejly A, Watad A, Adawi M, Amital H, Shoenfeld Y (2020) ASIA syndrome and endocrine autoimmune disorders. Best Pract Res Clin Endocrinol Metab 34(1):101412. https://doi.org/10.1016/j.beem.2020.101412CrossRefPubMed

23.

Colafrancesco S, Perricone C, Tomljenovic L, Shoenfeld Y (2013) Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/ inflammatory syndrome induced by adjuvants. Am J Reprod Immunol 70:309–316. https://doi.org/10.1111/aji.12151CrossRefPubMed

24.

Alvarez-Soria MJ, Hernandez-Gonzalez A, Carrasco-Garcia de Leon S, del Real-Francia MA, Gallardo-Alcaniz MJ, Lopez-Gomez JL (2011) Demyelinating disease and vaccination of the human papillomavirus. Rev Neurol 52:472–476PubMed

25.

Olivieri B, Betterle C, Zanoni G (2021) Vaccinations and autoimmune diseases. Vaccines (Basel). 9(8):815. https://doi.org/10.3390/vaccines9080815CrossRefPubMedPubMedCentral

26.

COVID-19_Actualizacion9_EstrategiaVacunacion.pdf (mscbs.gob.es)

27.

World Health Organization. Immunization Safety Surveillance: guidelines for immunization programme managers on surveillance of adverse events following immunization, 3rd ed.; WHO: Geneva, Switzerland, 2016; pp. 1–169

Titel: Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion
verfasst von: B. Pla Peris
A. Á. Merchante Alfaro
F. J. Maravall Royo
P. Abellán Galiana
S. Pérez Naranjo
M. González Boillos
Publikationsdatum: 01.05.2022
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 5/2022
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-022-01739-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion

Abstract